Hepcidin and ferritin levels as markers of immune cell activation during septic shock, severe COVID-19 and sterile inflammation
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F23%3A00013512" target="_blank" >RIV/00023736:_____/23:00013512 - isvavai.cz</a>
Alternative codes found
RIV/00159816:_____/23:00079723 RIV/00216224:14110/23:00130268
Result on the web
<a href="https://doi.org/10.3389/fimmu.2023.1110540" target="_blank" >https://doi.org/10.3389/fimmu.2023.1110540</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fimmu.2023.1110540" target="_blank" >10.3389/fimmu.2023.1110540</a>
Alternative languages
Result language
angličtina
Original language name
Hepcidin and ferritin levels as markers of immune cell activation during septic shock, severe COVID-19 and sterile inflammation
Original language description
Major clinically relevant inflammatory events such as septic shock and severe COVID-19 trigger dynamic changes in the host immune system, presenting promising candidates for new biomarkers to improve precision diagnostics and patient stratification. Hepcidin, a master regulator of iron metabolism, has been intensively studied in many pathologies associated with immune system activation, however these data have never been compared to other clinical settings. Thus, we aimed to reveal the dynamics of iron regulation in various clinical settings and to determine the suitability of hepcidin and/or ferritin levels as biomarkers of inflammatory disease severity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in immunology
ISSN
1664-3224
e-ISSN
—
Volume of the periodical
14
Issue of the periodical within the volume
January
Country of publishing house
CH - SWITZERLAND
Number of pages
10
Pages from-to
—
UT code for WoS article
000929110400001
EID of the result in the Scopus database
2-s2.0-85147753161